RxDoctor Payments DataLook up a doctor →

Paul Fidrych

Nurse Practitioner · Norwich, CTNPI 1972121630

Payments from drug & device makers

$23,298in general payments, 2019–2025

Across 950 payments — averaging $24.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • EMD Serono, Inc.$3K
  • Novartis$2K
  • Pfizer$1K
  • Eisai Inc.$983
  • Biogen$892
  • plus $10K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)224$4,974
EMD Serono, Inc.89$3,379
Novartis79$2,067
Pfizer72$1,438
Eisai Inc.22$983
Biogen42$892
TG Therapeutics, Inc.25$879
Lundbeck LLC31$834
UCB, Inc.30$785
Amgen(2 entities)27$583
SK Life Science, Inc.20$453
Octapharma USA, Inc.9$451
Bristol Myers Squibb23$434
Amneal Pharmaceuticals LLC21$423
Teva Pharmaceuticals USA, Inc.23$397
AstraZeneca(2 entities)21$381
Johnson & Johnson(2 entities)15$358
Lilly USA, LLC14$248
CSL Behring12$238
Otsuka America Pharmaceutical, Inc.8$225
Biohaven Pharmaceutical Holding Company Ltd.10$222
Scilex Pharmaceuticals Inc.10$218
Sanofi11$210
Genentech USA, Inc.9$191
Takeda Pharmaceuticals U.S.A., Inc.9$171
Sunovion Pharmaceuticals Inc.9$134
Mallinckrodt Hospital Products Inc.6$122
Axsome Therapeutics, Inc.5$116
Vanda Pharmaceuticals Inc.5$111
Cycle Pharmaceuticals Inc3$111
E.r. Squibb & Sons, L.L.C.1$89
Avanir Pharmaceuticals, Inc.4$88
Argenx US, Inc.3$76
Upsher-smith Laboratories LLC5$75
Tanabe Pharma America, Inc.4$75
Kyowa Kirin, Inc.4$73
Neurocrine Biosciences, Inc.3$63
GE HealthCare2$57
Ipsen Biopharmaceuticals, Inc3$51
Alnylam Pharmaceuticals Inc.3$50
Azurity Pharmaceuticals, Inc.3$47
Averitas Pharma Inc.2$45
Collegium Pharmaceutical, Inc.2$44
MDD US Operations, LLC2$44
Impel Pharmaceuticals Inc.3$43
Tonix Medicines, Inc.2$39
Kedrion Biopharma, Inc.2$39
Sumitomo Pharma America, Inc.4$39
Amylyx Pharmaceuticals, Inc.2$37
Life Molecular Imaging Ltd3$35
Merz Pharmaceuticals, LLC2$32
Currax Pharmaceuticals LLC2$28
ANI Pharmaceuticals, Inc.1$25
Supernus Pharmaceuticals, Inc.1$25
Almatica Pharma LLC1$20
Grifols USA, LLC1$16
Biohaven Pharmaceuticals, Inc.1$14

How this compares

$23,298 in reported general payments places this provider in the 95th percentile of 1,162 nurse practitioner providers in Connecticut.

See all nurse practitioner providers in Connecticut →

Medicare billing

Part B allowed, 2024
$38,279
Medicare patients
206
Services billed
1,301

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Norwich

See the full list for Connecticut →

Where these figures come from

Is this you, or does something look wrong? →